Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
News
news
Press releases & other news
Subscribe
Sep 2, 2013
Disputas - Sivilingeniør Ketil André Camilio
Les omtale på norsk
Back
